NOVOCURE LIMITED |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 27.42 USD | +4.80% |
|
+4.12% | -8.36% |
| Dec. 02 | HC Wainwright Adjusts NovoCure Price Target to $38 From $30, Maintains Buy Rating | MT |
| Dec. 02 | NovoCure's Shares Rise as Pancreatic Cancer Trial Meets Primary Endpoint | MT |
Chart calendar NovoCure Limited
4c6bb5200a1d728e9b7a906.No1hQscWvwgFf5zmJhGsZRRofBTrH9fiLlaYqkKvgno.cMJXFY1CzVtaDuWRQlTgIHg9TFyhUe-rVDf3_CCYzTR_wyktsl35RUk2_w~974db7981f05a63b2e72f99be89f2b53
Upcoming events on NovoCure Limited
Past events on NovoCure Limited
| 2025-01-15 12:00 pm | JP Morgan Healthcare Conference |
| 2024-12-05 12:00 pm | Piper Sandler Healthcare Conference |
| 2024-12-04 02:10 pm | Evercore ISI HealthCONx Conference |
| 2024-11-24 09:30 am | Society for Neuro Oncology Scientific Meeting - Abstract No:TMOD-09 |
| 2024-11-22 08:30 pm | Society for Neuro Oncology Scientific Meeting - Poster No:INNV-14 |
| 2024-11-22 08:30 pm | Society for Neuro Oncology Scientific Meeting - Poster No:INNV-11 |
| 2024-10-30 08:00 am | Q3 2024 Earnings Call |
| 2024-10-30 07:00 am | Q3 2024 Earnings Release |
| 2024-09-16 07:00 am | European Society for Medical Oncology Meeting |
| 2024-09-15 | European Society for Medical Oncology Meeting - Poster No. #459 |
| 2024-09-08 09:00 pm | International Association for the Study of Lung Cancer World Conference |
| 2024-09-08 03:00 pm | International Association for the Study of Lung Cancer World Conference - Poster P1.098B.04 |
| 2024-09-06 | International Association for the Study of Lung Cancer World Conference - Poster EP.03F.04 |
| 2024-09-06 | International Association for the Study of Lung Cancer World Conference - Poster EP.03G.03 |
| 2024-09-04 04:30 pm | Wells Fargo Healthcare Conference |
| 2024-07-25 08:00 am | Q2 2024 Earnings Call |
| 2024-07-25 07:00 am | Q2 2024 Earnings Release |
| 2024-06-05 09:00 am | Annual General Meeting |
| 2024-06-03 11:24 am | American Society of Clinical Oncology Meeting - Abstract Number - #2008 |
| 2024-05-02 08:00 am | Q1 2024 Earnings Call |
Annual results
| Fiscal Period | December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 535 539 -0.81% | 538 537 0.15% | 509 509 -0.01% | 605 | 620 | 684 |
|
EBITDA Million USD | Released Forecast Spread | -34,1 -20,6 -65.7% | -78,9 -43,7 -80.45% | -222 -233 4.77% | -142 | -171 | -164 |
|
EBIT Million USD | Released Forecast Spread | -44,3 -28,8 -53.83% | -89,5 -77,0 -16.3% | -233 -246 5.21% | -149 | -187 | -186 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -52,1 -36,7 -41.76% | -81,8 -79,7 -2.67% | -192 -208 7.72% | -107 | -164 | -174 |
|
Net income Million USD | Released Forecast Spread | -58,4 -41,1 -41.81% | -92,5 -88,0 -5.13% | -207 -217 4.38% | -140 | -176 | -178 |
|
EPS USD | Released Forecast Spread | -0,56 -0,41 -37.32% | -0,88 -0,82 -6.68% | -1,95 -2,02 3.64% | -1,29 | -1,59 | -1,60 |
| Announcement Date | 24/02/22 | 23/02/23 | 22/02/24 | - |
Quarterly results
| Fiscal Period | September | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 | 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | 2026 Q3 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 122 128 -4.49% | 126 124 1.45% | 127 129 -1.12% | 134 134 -0.01% | 139 131 5.37% | 150 136 10.7% | 155 144 7.74% | 161 | 152 | 154 | 157 | 159 | 169 | 174 | 180 |
|
EBITDA Million USD | Released Forecast Spread | -57,5 -36,2 -58.72% | -59,9 -54,6 -9.7% | -55,4 -60,5 8.34% | -49,0 -59,1 17.12% | -38,7 -59,0 34.35% | -30,7 -51,6 40.46% | -29,6 -44,4 33.18% | -41,7 | -43,5 | -41,3 | -39,3 | -40,5 | -38,6 | -35,7 | -33,9 |
|
EBIT Million USD | Released Forecast Spread | -60,2 -35,5 -69.72% | -62,7 -60,2 -4.15% | -58,2 -65,5 11.12% | -51,7 -64,6 19.94% | -41,5 -53,8 22.83% | -33,6 -50,1 32.91% | -32,1 -44,3 27.48% | -41,1 | -47,2 | -48,4 | -49,1 | -50,7 | -41,4 | -38,5 | -36,8 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -51,1 -35,5 -43.89% | -53,9 -51,0 -5.71% | -48,2 -56,8 15.1% | -38,5 -54,7 29.49% | -31,6 -41,4 23.66% | -22,7 -40,9 44.37% | -21,6 -33,9 36.25% | -31,0 | -37,3 | -38,5 | -40,3 | -43,1 | -32,9 | -30,0 | -28,3 |
|
Net income Million USD | Released Forecast Spread | -53,1 -37,9 -40.18% | -57,4 -52,2 -9.94% | -49,5 -56,0 11.65% | -47,1 -56,6 16.75% | -38,8 -45,1 14.15% | -33,4 -44,2 24.48% | -30,6 -37,7 18.83% | -36,9 | -43,1 | -44,6 | -46,8 | -49,7 | -40,9 | -38,0 | -36,3 |
|
EPS USD | Released Forecast Spread | -0,50 -0,34 -47.06% | -0,54 -0,50 -8% | -0,46 -0,53 12.38% | -0,45 -0,52 13.7% | -0,36 -0,42 14.24% | -0,31 -0,40 23.05% | -0,28 -0,33 16.22% | -0,34 | -0,38 | -0,40 | -0,43 | -0,47 | -0,37 | -0,34 | -0,33 |
| Announcement Date | 04/05/23 | 27/07/23 | 26/10/23 | 22/02/24 | 02/05/24 | 25/07/24 | 30/10/24 | - | - | - | - | - | - | - | - |
| 2025-01-28 02:00 am | GETINGE AB: Q4 2024 Earnings Release |
| 2025-02-04 | CHEMOMETEC A/S: Q2 2025 Earnings Release |
| 2025-02-13 | ASAHI INTECC CO., LTD.: Q2 2025 Earnings Release |
| 2025-02-14 02:00 am | IMPLANTICA AG: Q4 2024 Earnings Release |
| 2025-02-24 | PENUMBRA, INC.: Q4 2024 Earnings Release (Projected) |
| 2025-02-25 04:05 pm | MASIMO CORPORATION: Q4 2024 Earnings Release |
| 2025-02-25 | ZIMVIE INC.: Q4 2024 Earnings Release (Projected) |
| 2025-02-27 07:00 am | NOVOCURE LIMITED: Q4 2024 Earnings Release |
| 2025-02-27 04:05 pm | TREACE MEDICAL CONCEPTS, INC.: Q4 2024 Earnings Release |
| 2025-03-02 | SI-BONE, INC.: Q4 2024 Earnings Release (Projected) |
Past sector events for NovoCure Limited
| 2024-11-15 02:00 am | IMPLANTICA AG: Q3 2024 Earnings Release |
| 2024-11-13 | ASAHI INTECC CO., LTD.: Q1 2025 Earnings Release |
| 2024-11-12 04:09 pm | SI-BONE, INC.: Q3 2024 Earnings Release |
| 2024-11-07 11:12 am | CHEMOMETEC A/S: Q1 2025 Sales and Revenue Release - Trading Statement |
| 2024-11-05 04:05 pm | MASIMO CORPORATION: Q3 2024 Earnings Release |
| 2024-10-30 | SHANDONG WEIGAO ORTHOPAEDIC DEVICE CO., LTD: Q3 2024 Earnings Release |
| 2024-10-30 04:05 pm | PENUMBRA, INC.: Q3 2024 Earnings Release |
| 2024-10-30 07:00 am | NOVOCURE LIMITED: Q3 2024 Earnings Release |
| 2024-10-29 | SHENZHEN YHLO BIOTECH CO., LTD.: Q3 2024 Earnings Release |
| 2024-10-28 | SHANGHAI SANYOU MEDICAL CO., LTD: Q3 2024 Earnings Release |
Quarterly revenue - Rate of surprise
Net sales - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- NVCR Stock
- Calendar NovoCure Limited